BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23948595)

  • 1. Suppression of cyclin D1 by plasmid-based short hairpin RNA ameliorated experimental pulmonary vascular remodeling.
    Zeng DX; Xu GP; Lei W; Wang R; Wang CG; Huang JA
    Microvasc Res; 2013 Nov; 90():144-9. PubMed ID: 23948595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-based short hairpin RNA against cyclin D1 attenuated pulmonary vascular remodeling in smoking rats.
    Zeng DX; Liu XS; Xu YJ; Wang R; Xiang M; Xiong WN; Ni W; Chen SX
    Microvasc Res; 2010 Jul; 80(1):116-22. PubMed ID: 20227424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-based short hairpin RNA against connective tissue growth factor attenuated monocrotaline-induced pulmonary vascular remodeling in rats.
    Wang R; Zhou SJ; Zeng DS; Xu R; Fei LM; Zhu QQ; Zhang Y; Sun GY
    Gene Ther; 2014 Nov; 21(11):931-7. PubMed ID: 25077774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway.
    Liu YY; Zhang WY; Wang CG; Huang JA; Jiang JH; Zeng DX
    Microvasc Res; 2020 Jul; 130():103988. PubMed ID: 32057731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of connective tissue growth factor by plasmid-based short hairpin RNA prevented pulmonary vascular remodeling in cigarette smoke-exposed rats.
    Wang R; Xu YJ; Liu XS; Zeng DX; Xiang M
    Arch Biochem Biophys; 2011 Apr; 508(1):93-100. PubMed ID: 21295007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1).
    Wang R; Ding X; Zhou S; Li M; Sun L; Xu X; Fei G
    Oncotarget; 2016 Nov; 7(45):72746-72757. PubMed ID: 27322082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
    Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
    Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
    Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
    Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCN2 promotes cigarette smoke-induced proliferation of rat pulmonary artery smooth muscle cells through upregulating cyclin D1 expression.
    Wang R; Xu YJ; Liu XS; Zeng DX; Xiang M
    J Cell Biochem; 2012 Jan; 113(1):349-59. PubMed ID: 21928352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
    Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.
    Yin J; You S; Li N; Jiao S; Hu H; Xue M; Wang Y; Cheng W; Liu J; Xu M; Yan S; Li X
    Respir Res; 2016 Aug; 17(1):99. PubMed ID: 27491388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
    Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of neuron-derived orphan receptor 1 with pulmonary vascular remodeling in COPD patients.
    Wang CG; Li C; Lei W; Jiang JH; Huang JA; Zeng DX
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1177-1186. PubMed ID: 29695901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
    Xu T; Liu S; Ma T; Jia Z; Zhang Z; Wang A
    Redox Biol; 2017 Apr; 11():286-296. PubMed ID: 28030785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn.
    Wedgwood S; Lakshminrusimha S; Czech L; Schumacker PT; Steinhorn RH
    Antioxid Redox Signal; 2013 May; 18(14):1765-76. PubMed ID: 23244636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
    Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
    McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
    J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
    Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R
    Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.